Prostate Cancer Screening—Where We’ve Been, Where We Are, and What Comes Next - Top-Institutions - MDSpire

Prostate Cancer Screening—Where We’ve Been, Where We Are, and What Comes Next

  • By

  • Saira Khan

  • Marvin Langston

  • Siobhan Sutcliffe

  • July 6, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    German Cancer Research Centre (DKFZ)
    German Cancer Research Centre (DKFZ)

    Heidelberg, Germany

    Key Differentiators

    • Urology

  • #2

    Karolinska Institute
    Karolinska Institute

    Stockholm, Sweden

    Key Differentiators

    • Urology

  • #3

    European Randomized Study of Screening for Prostate Cancer (ERSPC)
    European Randomized Study of Screening for Prostate Cancer (ERSPC)

    Multiple Locations, N/A

    Key Differentiators

    • Urology

Original Source(s)

Prostate Cancer Screening—Where We’ve Been, Where We Are, and What Comes Next

  • by Saira Khan, Marvin Langston, Siobhan Sutcliffe

  • July 6, 2026

Related Content

Sex and gender-oriented colorectal cancer screening: a consensus study from the AIOM- GISEG working group

Dendritic cells in cancer immunotherapy: functional barriers, reprogramming strategies and translational challenges

TREM1 unleashes immunosuppression in glioma: targeting macrophage polarization as a new therapeutic vulnerability